Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanara MedTech is a medical technology company focused on developing and commercializing transformative products for the surgical, chronic wound, and skin care markets. The company's portfolio includes advanced biologic products such as CellerateRX and HYCOL, which utilize activated and hydrolyzed collagen to promote healing in various wound types. Sanara also markets the Sanacute line of skin protectants, specifically designed to manage and prevent skin breakdown associated with incontinence and moisture. By providing a comprehensive suite of products that address biofilm management and tissue regeneration, Sanara MedTech aims to improve clinical outcomes and reduce the total cost of care for patients with complex skin and wound conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanacute Skin Care.